Kristyn Whitmore, Zhen Zhou, Costan G Magnussen, Mark R Nelson, Melinda J Carrington
{"title":"心血管疾病一级预防中提高降脂治疗依从性的策略综述","authors":"Kristyn Whitmore, Zhen Zhou, Costan G Magnussen, Mark R Nelson, Melinda J Carrington","doi":"10.1093/eurjpc/zwaf237","DOIUrl":null,"url":null,"abstract":"<p><p>Poor adherence to lipid-lowering therapy (LLT) is a major barrier in the prevention of cardiovascular disease (CVD) worldwide. The burden of CVD can be significantly reduced by LLT, particularly in populations with high cardiovascular (CV) risk. Despite established benefits from LLT, efforts to improve adherence have had varying degrees of success in the primary prevention. Adherence is a multifactorial process and requires tailored strategies to address an individual's specific needs. Despite numerous studies exploring strategies to improve medication adherence, empirical evidence indicates that adherence to LLT remains a persistent challenge. Strategies used to improve long-term LLT adherence in the primary prevention can be grouped into four themes: (i) individualized CV education; (ii) emotional engagement with CV prevention; (iii) mobile health prompts; and (iv) approaches to improving patient acceptability of LLT. This review will revisit the strategies used to improve LLT adherence in the primary prevention of CVD and evaluate their effectiveness in promoting long-term adherence. Future perspectives for enhancing LLT adherence will explore the application of behavioural economic principles to facilitate shared decision-making, the development of novel communication strategies, and implementation of targeted interventions.</p>","PeriodicalId":12051,"journal":{"name":"European journal of preventive cardiology","volume":" ","pages":"1204-1215"},"PeriodicalIF":7.5000,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Review of strategies to improve adherence to lipid-lowering therapy in the primary prevention of cardiovascular disease.\",\"authors\":\"Kristyn Whitmore, Zhen Zhou, Costan G Magnussen, Mark R Nelson, Melinda J Carrington\",\"doi\":\"10.1093/eurjpc/zwaf237\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Poor adherence to lipid-lowering therapy (LLT) is a major barrier in the prevention of cardiovascular disease (CVD) worldwide. The burden of CVD can be significantly reduced by LLT, particularly in populations with high cardiovascular (CV) risk. Despite established benefits from LLT, efforts to improve adherence have had varying degrees of success in the primary prevention. Adherence is a multifactorial process and requires tailored strategies to address an individual's specific needs. Despite numerous studies exploring strategies to improve medication adherence, empirical evidence indicates that adherence to LLT remains a persistent challenge. Strategies used to improve long-term LLT adherence in the primary prevention can be grouped into four themes: (i) individualized CV education; (ii) emotional engagement with CV prevention; (iii) mobile health prompts; and (iv) approaches to improving patient acceptability of LLT. This review will revisit the strategies used to improve LLT adherence in the primary prevention of CVD and evaluate their effectiveness in promoting long-term adherence. Future perspectives for enhancing LLT adherence will explore the application of behavioural economic principles to facilitate shared decision-making, the development of novel communication strategies, and implementation of targeted interventions.</p>\",\"PeriodicalId\":12051,\"journal\":{\"name\":\"European journal of preventive cardiology\",\"volume\":\" \",\"pages\":\"1204-1215\"},\"PeriodicalIF\":7.5000,\"publicationDate\":\"2025-09-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European journal of preventive cardiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/eurjpc/zwaf237\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of preventive cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/eurjpc/zwaf237","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Review of strategies to improve adherence to lipid-lowering therapy in the primary prevention of cardiovascular disease.
Poor adherence to lipid-lowering therapy (LLT) is a major barrier in the prevention of cardiovascular disease (CVD) worldwide. The burden of CVD can be significantly reduced by LLT, particularly in populations with high cardiovascular (CV) risk. Despite established benefits from LLT, efforts to improve adherence have had varying degrees of success in the primary prevention. Adherence is a multifactorial process and requires tailored strategies to address an individual's specific needs. Despite numerous studies exploring strategies to improve medication adherence, empirical evidence indicates that adherence to LLT remains a persistent challenge. Strategies used to improve long-term LLT adherence in the primary prevention can be grouped into four themes: (i) individualized CV education; (ii) emotional engagement with CV prevention; (iii) mobile health prompts; and (iv) approaches to improving patient acceptability of LLT. This review will revisit the strategies used to improve LLT adherence in the primary prevention of CVD and evaluate their effectiveness in promoting long-term adherence. Future perspectives for enhancing LLT adherence will explore the application of behavioural economic principles to facilitate shared decision-making, the development of novel communication strategies, and implementation of targeted interventions.
期刊介绍:
European Journal of Preventive Cardiology (EJPC) is an official journal of the European Society of Cardiology (ESC) and the European Association of Preventive Cardiology (EAPC). The journal covers a wide range of scientific, clinical, and public health disciplines related to cardiovascular disease prevention, risk factor management, cardiovascular rehabilitation, population science and public health, and exercise physiology. The categories covered by the journal include classical risk factors and treatment, lifestyle risk factors, non-modifiable cardiovascular risk factors, cardiovascular conditions, concomitant pathological conditions, sport cardiology, diagnostic tests, care settings, epidemiology, pharmacology and pharmacotherapy, machine learning, and artificial intelligence.